Vertex provides help to businesses struggling with tax compliance in the digital age
13 nov. 2019 05h00 HE
|
World Finance
LONDON, Nov. 13, 2019 (GLOBE NEWSWIRE) -- It’s often said that there are only two certainties in life: death and taxes. But just because taxation is unavoidable, doesn’t mean it is necessarily...
Arbor Biotechnologies Announces New Discoveries and Addition to its Board
03 janv. 2019 08h58 HE
|
Arbor Biotechnologies Inc
Discovers three new CRISPR-Cas systems, findings published in the journal ScienceAppoints Paul Meister to its Board of Directors CAMBRIDGE, Mass., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Arbor...
The importance of rethinking tax policies to meet the changing requirements of the digital age
12 sept. 2018 05h37 HE
|
World Finance
LONDON, Sept. 12, 2018 (GLOBE NEWSWIRE) -- In the digital era, tax authorities are aggressively pursuing new ways of capturing revenue. While new digital economy taxation proposals put forward by...
Executives must understand the strategic importance of tax functions in order to prosper in an ever-changing global tax environment
20 août 2018 05h00 HE
|
World Finance
LONDON, Aug. 20, 2018 (GLOBE NEWSWIRE) -- While the global tax policy environment continues to change at a dizzying pace, technological advances are simultaneously transforming the sector. ...
INVESTORS SAY EXECUTIVE PAY PACKAGES AT PHARMA MAY INCENTIVIZE DRUG PRICING RISKS
13 déc. 2017 13h13 HE
|
Azzad Funds
Falls Church, Dec. 13, 2017 (GLOBE NEWSWIRE) -- SOURCE - AZZAD ASSET MANAGEMENT Investors today announced they have filed resolutions at five major pharmaceutical companies asking for information...
Parion Sciences Announces Upcoming Presentations of Data at the North American Cystic Fibrosis Conference Being Held October 8 through 10, 2015
05 oct. 2015 08h12 HE
|
Parion Sciences
Data From Preclinical and Clinical Research on P-1037(VX-371) to be PresentedAdditional Data Presentation Includes a Review of a Novel in Silico Approach Towards Identification of CFTR...
CLEAN-CF Clinical Trial Expanded to Include Pediatric Cystic Fibrosis Population
10 sept. 2015 09h35 HE
|
Parion Sciences
DURHAM, N.C., Sept. 10, 2015 (GLOBE NEWSWIRE) -- Parion Sciences, a company dedicated to the development of novel treatments for pulmonary and ocular diseases, announced today that the CLEAN-CF...
Vertex and Parion Sciences Establish Collaboration to Develop Epithelial Sodium Channel (ENaC) Inhibitors in Cystic Fibrosis and Other Pulmonary Diseases
04 juin 2015 16h01 HE
|
Parion Sciences
-ENaC inhibition aims to restore or improve hydration of cell surfaces in the lungs to improve lung function- -Parion to receive $80 million up-front payment with potential for additional development...